(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
NCT 05907954 Brief Summary Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal…
Read more arrow_forwardNCT 05907954 Brief Summary Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal…
Read more arrow_forwardNCT 05086692 Brief Summary This is a Phase 1/2, multi-center, open-label, dose-escalation…
Read more arrow_forwardNCT 05763004 Brief Summary The goal of this clinical trial is to…
Read more arrow_forwardNCT 06625593 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06422520 Brief Summary This is a first-in-human, Phase 1a/1b study to…
Read more arrow_forwardNCT 06914128 Brief Summary The study treatment, BAY 3713372, is under development…
Read more arrow_forwardNCT 05858164 Brief Summary Researchers are looking for a better way…
Read more arrow_forwardNCT 05999994 Brief Summary The main purpose of the master is to…
Read more arrow_forwardACTRN 12623000108617 Brief Summary This study aims to assess a new cancer…
Read more arrow_forwardACTRN 12624000085572 Brief Summary This study aims to assess the safety and…
Read more arrow_forward